Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene.

Pasquale F, Syrris P, Kaski JP, Mogensen J, McKenna WJ, Elliott P.

Circ Cardiovasc Genet. 2012 Feb 1;5(1):10-7. doi: 10.1161/CIRCGENETICS.111.959973. Epub 2011 Dec 5.

2.

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.

Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.

Rev Port Cardiol. 2005 Mar;24(3):407-15. English, Portuguese.

PMID:
15929624
3.

Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients.

García-Castro M, Reguero JR, Batalla A, Díaz-Molina B, González P, Alvarez V, Cortina A, Cubero GI, Coto E.

Clin Chem. 2003 Aug;49(8):1279-85.

4.

Sudden death due to troponin T mutations.

Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Watkins H.

J Am Coll Cardiol. 1997 Mar 1;29(3):549-55.

5.

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA 3rd, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS.

J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037.

6.

Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.

Kokado H, Shimizu M, Yoshio H, Ino H, Okeie K, Emoto Y, Matsuyama T, Yamaguchi M, Yasuda T, Fujino N, Ito H, Mabuchi H.

Circulation. 2000 Aug 8;102(6):663-9.

7.

Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.

Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, Jefferies JL, Kim JJ, Price JF, Dreyer WJ, Towbin JA, Denfield SW.

J Am Coll Cardiol. 2009 Jul 14;54(3):250-4. doi: 10.1016/j.jacc.2009.03.051.

8.

Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy.

Ho CY, Lever HM, DeSanctis R, Farver CF, Seidman JG, Seidman CE.

Circulation. 2000 Oct 17;102(16):1950-5.

9.

Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy.

Fujino N, Shimizu M, Ino H, Okeie K, Yamaguchi M, Yasuda T, Kokado H, Mabuchi H.

Clin Cardiol. 2001 May;24(5):397-402.

PMID:
11346248
10.

[Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].

Sadoul N, de Chillou C, Aliot E, McKenna WJ.

Arch Mal Coeur Vaiss. 1999 Apr;92 Spec No 1:65-73. Review. French.

PMID:
10326160
11.

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.

Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ.

J Am Coll Cardiol. 1999 May;33(6):1596-601.

12.

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.

Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, et al.

N Engl J Med. 1995 Apr 20;332(16):1058-64.

13.

Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations.

Heradien M, Revera M, van der Merwe L, Goosen A, Corfield VA, Brink PA, Mayosi BM, Moolman-Smook JC.

Heart Rhythm. 2009 Nov;6(11 Suppl):S18-24. doi: 10.1016/j.hrthm.2009.07.020. Epub 2009 Sep 1.

14.

Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.

Mogensen J, Murphy RT, Kubo T, Bahl A, Moon JC, Klausen IC, Elliott PM, McKenna WJ.

J Am Coll Cardiol. 2004 Dec 21;44(12):2315-25.

15.

Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.

Varnava AM, Elliott PM, Baboonian C, Davison F, Davies MJ, McKenna WJ.

Circulation. 2001 Sep 18;104(12):1380-4.

16.

A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy.

Varnava A, Baboonian C, Davison F, de Cruz L, Elliott PM, Davies MJ, McKenna WJ.

Heart. 1999 Nov;82(5):621-4.

17.

A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy.

Fujino N, Shimizu M, Ino H, Yamaguchi M, Yasuda T, Nagata M, Konno T, Mabuchi H.

Am J Cardiol. 2002 Jan 1;89(1):29-33.

PMID:
11779518
18.

[A novel missense mutation, K124N, in the troponin T gene of Chinese populations with hypertrophic cardiomyopathy].

An FS, Zhang Y, Li DQ, Yang XS, Li L, Zhang C, Yan ML, Wang Y, An GP.

Zhonghua Yi Xue Za Zhi. 2004 Aug 17;84(16):1340-3. Chinese.

PMID:
15387941
19.

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.

Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ.

J Am Coll Cardiol. 2003 Sep 3;42(5):873-9.

20.

Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P.

N Engl J Med. 2000 Feb 10;342(6):365-73.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk